Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-046463·Longwood Fund III, L.P.
Schedule 13G ownership disclosure
WEREWOLF THERAPEUTICS INC
Common Stock · CUSIP: 95075A107
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Longwood Fund III GP, LLC
Shares: 1,677,082 · Class: 3.5%
- Longwood Fund III, L.P.
Shares: 1,677,082 · Class: 3.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-046463
- Form type
- SCHEDULE 13G/A
- Filer
- Longwood Fund III, L.P.
- CIK
- CIK 1640546
- Filed
- Feb 11, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership